Divis Laboratories Ltd | DIVI - Debt


Divis Laboratories Ltd reported INR70M in Debt for its fiscal quarter ending in March of 2026.





Debt Change Date
Alaunos Therapeutics USD 10.99M 5.78M Mar/2023
Aurobindo Pharma INR 80.73B 1.9B Mar/2026
Avita Medical AUD 46.05M 1.46M Dec/2025
Dianthus Therapeutics USD 1.36M 79K Mar/2026
Divis Laboratories Ltd INR 70M 30M Mar/2026
Ionis Pharmaceuticals USD 1.91B 425.5M Jun/2026
IQVIA Holdings USD 16.24B 408M Jun/2026
Lupin INR 66.16B 11.68B Mar/2026
Moderna USD 1.3B 7M Mar/2026
Organon & Co USD 8.55B 16M Jun/2026
Revvity USD 3.35B 48.03M Mar/2026
Tectonic Therapeutic USD 876K 115K Dec/2024
Tilray USD 640.95M 35.17M Jun/2022
Viatris USD 13.35B 993.3M Jun/2026
Xeris Pharmaceuticals USD 258.55M 899K Mar/2026